Rilexine 300 mg 100 Chewable Tablets
Key product information
Important product information
Review product information, ingredients, storage, warnings, and other important details before ordering.
Overview
Read the product description and usage details.
Overview
Indicated for the treatment of superficial pyoderma in dogs caused by susceptible strains of Staphylococcus pseudintermedius. Each chewable, bisected tablet contains 300 mg or 600 mg cephalexin depending on the strenght chosen (as cephalexin monohydrate). 100 tablets.
Product Details
| DIN (Drug Identification Number) | 02442701 |
| Active Ingredients | 300 mg or 600 mg cephalexin depending on the strenght chosen (as cephalexin monohydrate) |
| Approved For | Dog |
| Therapeutic Use | Antibiotic |
| Form | Chewable tablet |
| Route of Administration | Oral |
| Strength / Concentration | 300 mg mg |
| Pack Size | 100 Chewable Tablets |
Safety & Storage
Storage: Ambient
Specifications
Review available public product specifications and handling details.
Basic Information
| Brand | Virbac |
|---|---|
| DIN | 2442701 |
| Active Ingredient | 300 mg or 600 mg cephalexin depending on the strenght chosen (as cephalexin monohydrate) |
| Strength | 300 mg mg |
| Pack Size | 100 Chewable Tablets |
Storage & Shipping
| Shipping Weight | 0.11 kg |
|---|---|
| Storage Conditions | Ambient |
Important Notice
Product information is provided for reference only and does not replace veterinary advice. Always follow your veterinarian’s direction for prescription products.